Speaker illustration

Mrs Maria Castineira Busto

University Hospital Alvaro Cunqueiro, Vigo (Spain)

Member of:

Prognostic impact of the new P2Y12 (ticagrelor and prasugrel) versus clopidogrel in acute coronary syndrome patients in relation to renal function

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Oral P2Y12 inhibitors in acute coronary syndromes: are they all equal?

Thumbnail

Differences in the ischemic-hemorrhagic balance between diabetic and non-diabetic patients treated with dual antiplatelet theraphy with ticagrelor and prasugrel

Event: ESC Congress 2018

Topic: Postinfarction Period

Session: Bleeding complications in ACS

Thumbnail

Value of 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography in the diagnosis of native, prosthetic and device related infective endocarditis

Event: EuroEcho-Imaging 2016

Topic: Nuclear cardiology

Session: Cardiac imaging with computed tomography and radionuclide techniques: usefulness in miscellaneous patient subsets

Thumbnail

This platform is supported by

logo Novo Nordisk